GOLDMAN SACHS GROUP INC - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of PULMONX CORP
ValueSharesWeighting
Q3 2023$1,160,008
-60.5%
112,295
-49.9%
0.00%
-100.0%
Q2 2023$2,936,325
+72.8%
223,976
+47.3%
0.00%
Q1 2023$1,699,696
-41.0%
152,030
-55.5%
0.00%
-100.0%
Q4 2022$2,879,047
-74.4%
341,524
-49.4%
0.00%
-66.7%
Q3 2022$11,241,000
+73.1%
674,734
+53.0%
0.00%
+200.0%
Q2 2022$6,493,000
-47.8%
441,104
-12.0%
0.00%
-66.7%
Q1 2022$12,430,000
+267.5%
501,022
+375.1%
0.00%
+200.0%
Q4 2021$3,382,000
-38.8%
105,456
-31.4%
0.00%0.0%
Q3 2021$5,530,000
+33.2%
153,704
+63.4%
0.00%0.0%
Q2 2021$4,151,000
+106.5%
94,080
+223.1%
0.00%0.0%
Q4 2020$2,010,00029,1180.00%
Other shareholders
PULMONX CORP shareholders Q3 2023
NameSharesValueWeighting ↓
ABG-WTT Global Life Science Capital Partners GP Ltd 815,019$37,279,00040.66%
Yu Fan 303,030$13,861,00036.18%
ABG Innovation Capital Partners III GP Ltd 833,333$38,117,00018.73%
KPCB XIII Associates, LLC 994,971$45,510,0009.36%
Iron Triangle Partners LP 600,000$27,444,0003.49%
Miura Global Management 405,000$18,525,0003.31%
GREAT POINT PARTNERS LLC 114,345$5,230,0001.08%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 937,032$42,860,0000.90%
ADAMS STREET PARTNERS LLC 114,661$5,245,0000.84%
RTW INVESTMENTS, LP 1,129,600$51,668,0000.81%
View complete list of PULMONX CORP shareholders